Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new post-hoc data from the KINECT® 4 clinical trial demonstrating that adults with tardive dyskinesia (TD) treated with INGREZZA® ...
Since the brain controls every function of the body, even a small tumour can sometimes lead to significant health problems.
I’ve become fairly impressed with the Yankees‘ work in the Undrafted Free Agent market, as they have found really interesting ...